The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Large Is The In-Vitro Diagnostics Instruments Market Projected To Become By 2030 Based On Its 2026 Valuation?
The in-vitro diagnostics instruments market has experienced substantial expansion in recent years. Its value is projected to increase from $61.09 billion in 2025 to $67.18 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.0%. This historical growth can be linked to factors such as the rising prevalence of chronic diseases, increasing hospital lab infrastructure, advances in diagnostic reagents, growing awareness for early disease detection, and government healthcare initiatives.
The in-vitro diagnostics instruments market is projected to experience substantial expansion over the upcoming years. By 2030, its value is anticipated to reach $99.44 billion, exhibiting a compound annual growth rate (CAGR) of 10.3%. This projected growth during the forecast period stems from factors such as advancements in molecular diagnostics technology, the rise of personalized medicine, the incorporation of artificial intelligence in diagnostics, the broadening healthcare landscape in emerging markets, and increasing demand for diagnostic tools usable at home. Key trends identified for the forecast period encompass the broadening scope of point-of-care testing, the development of personalized diagnostics, the quick uptake of molecular testing methods, the integration of remote patient monitoring systems, and the increasing use of miniaturized laboratory instruments.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=29107&type=smp
Which Market Drivers Are Supporting The Expansion Of The In-Vitro Diagnostics Instruments Market?
The expansion of the in vitro diagnostics instruments market is anticipated to be driven by the increasing occurrence of chronic and lifestyle-related diseases. These conditions encompass enduring health issues predominantly shaped by daily routines, habits, and environmental elements, including heart disease, diabetes, obesity, and specific cancers. The rise in chronic and lifestyle-related diseases stems from inactive lifestyles and poor dietary choices. Solutions within the in vitro diagnostics instruments sector are experiencing heightened demand, as the swift growth of chronic and lifestyle-related diseases encourages businesses to implement tools for early detection and monitoring to enhance disease management. For instance, data from 2024, provided by the American Action Forum, a US-based non-profit, center-right think tank, highlights that chronic diseases continue to be a substantial public health issue in the U.S., affecting nearly 60 percent of adults with at least one condition, 40 percent with multiple conditions, and projecting a near doubling of prevalence by 2050. Moreover, the market for chronic disease treatment is forecast to reach approximately USD 38.02 billion by 2034, representing a notable increase from USD 9.74 billion in 2025. Consequently, the growing incidence of chronic and lifestyle-related diseases is fueling the demand for the in vitro diagnostics instruments market.
What Segment Groups Are Identified Within The In-Vitro Diagnostics Instruments Market?
The in-vitro diagnostics instruments market covered in this report is segmented –
1) By Product Type: Clinical Chemistry, Immunoassay, Molecular Diagnostics, Hematology, Microbiology, Coagulation, Other Product Types
2) By Application: Infectious Diseases, Cancer, Cardiology, Nephrology, Autoimmune Diseases, Other Applications
3) By End User: Hospitals And Diagnostic Laboratories, Academic And Research Institutes, Point-Of-Care Settings, Blood Banks, Pharmaceutical And Biotechnology Companies, Other Healthcare Facilities
Subsegments:
1) By Clinical Chemistry: Automated Clinical Chemistry Analyzers, Semi-Automated Clinical Chemistry Analyzers, Point-Of-Care Clinical Chemistry Devices
2) By Immunoassay: Enzyme-Linked Immunosorbent Assay (ELISA) Systems, Chemiluminescence Immunoassay (CLIA) Analyzers, Radioimmunoassay (RIA) Systems
3) By Molecular Diagnostics: Polymerase Chain Reaction (PCR) Systems, Next-Generation Sequencing (NGS) Platforms, Deoxyribonucleic Acid Microarrays, Isothermal Amplification Devices
4) By Hematology: Automated Hematology Analyzers, Manual Hematology Analyzers, Hemostasis Analyzers, Coagulation Analyzers
5) By Microbiology: Microbial Identification Systems, Antibiotic Susceptibility Testing (AST) Systems, Blood Culture Systems, Automated Microbial Analyzers.
6) By Coagulation: Coagulometers, Platelet Function Analyzers, Thromboelastography (TEG) Systems, Point-Of-Care Coagulation Devices
7) By Other Product Types: Point-Of-Care Diagnostic Devices, Miscellaneous Laboratory Instruments
What Trends Are Advancing Progress In The In-Vitro Diagnostics Instruments Market?
Leading firms within the in-vitro diagnostics instruments market are prioritizing the creation of sophisticated products, including digital polymerase chain reaction (dPCR) systems, to facilitate highly accurate and sensitive nucleic acid quantification essential for advanced diagnostics. These dPCR systems serve as cutting-edge diagnostic instruments capable of precisely measuring DNA or RNA molecules by dividing samples into thousands of separate reactions, thereby ensuring highly accurate and sensitive detection. For example, QIAGEN N.V., a biotechnology company based in the Netherlands, introduced the QIAcuityDx Digital PCR System in September 2024, extending its digital PCR offerings into clinical diagnostics, particularly for oncology testing. This fully integrated and automated system is specifically engineered for clinical oncology testing, incorporating a cartridge-based workflow to reduce manual intervention. The QIAcuityDx comes equipped with automated analysis and reporting software, facilitating swift and accurate identification of genetic biomarkers for cancer diagnosis and treatment monitoring with minimal need for operator involvement.
Which Companies Hold Significant Positions In The In-Vitro Diagnostics Instruments Market?
Major companies operating in the in-vitro diagnostics instruments market are F. Hoffmann-La Roche Ltd, Danaher Corporation, Abbott Laboratories, Thermo Fisher Scientific, Siemens Healthineers AG, Becton Dickinson and Company, Sysmex Corporation, Bio-Rad Laboratories Inc, Agilent Technologies, Hologic Inc, Qiagen N.V., Illumina Inc, Ortho Clinical Diagnostics, Beckman Coulter Inc, Mindray Medical International Limited, Horiba Ltd, Randox Laboratories Ltd, DiaSorin S.p.A., Werfen S.A., Trinity Biotech plc
Read the full in-vitro diagnostics instruments market report here:
How Is The In-Vitro Diagnostics Instruments Market Distributed Across Key Geographic Regions?
North America was the largest region in the in-vitro diagnostics instruments market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in-vitro diagnostics instruments market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored In-Vitro Diagnostics Instruments Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=29107&type=smp
Browse Through More Reports Similar to the Global In-Vitro Diagnostics Instruments Market 2026, By The Business Research Company
Intravenous Iv Hydration Therapy Market Report 2026
Intravenous Immunoglobulin Market Report 2026
https://www.thebusinessresearchcompany.com/report/intravenous-immunoglobulin-global-market-report
Intravenous Infusion Pumps Market Report 2026
https://www.thebusinessresearchcompany.com/report/intravenous-infusion-pumps-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model